Former Johnson & Johnson Robotics Head Joins Radiosurgery Leader Accuray as Chief Commercial Officer

Source: Medical Device Business Review

On April 6, 2026, Accuray Incorporated (NASDAQ: ARAY), a supplier of cancer radiotherapy systems, issued an announcement.Paul Miele officially assumes the role of Senior Vice President and Chief Commercial Officer (CCO) of the company as of today, and joins the executive leadership team.

Before joining Accuray, Paul Miele's most recent professional experience wasHead and General Manager of the MONARCH™ Robotic Platform Business Unit, Johnson & Johnson Medical Technologies。

Paul Miele

Public information shows that in this position,Miele led a series of business operation adjustments, including reshaping the operating model, reactivating the existing customer base, and strengthening the monetization capability of services and solutions. According to the official statement, it was under his leadership that this platform successfully reversed the previous decline in revenue and achieved double-digit annual sales growth during his tenure.

Earlier, he held senior commercial positions at Globus Medical and Intuitive Surgical.

In terms of business attributes, the MONARCH robotic platform is an auxiliary system for bronchoscopic diagnosis and treatment, while Accuray's core product lines, CyberKnife and Radixact systems, focus on the field of precision radiotherapy.Although they are in different clinical细分 tracks,But at the underlying logic of the business model, all involve the sales cycle management of high-ticket capital equipment, all face the industry trend of transitioning from one-time equipment delivery to recurring service revenue, and all need to address the resource allocation issues between existing customer operations and incremental market expansion.

Accuray President and CEO Steve La Neve Highlighted Core Expectations for Miele in the Personnel Announcement: "Accelerating Capital Equipment Sales" and "Tapping Recurring Revenue Opportunities."

Visible,Accuray has not abandoned the expansion of its fundamental base of installed equipment, but a more urgent task is to increase the proportion of service revenue in order to optimize the resilience of financial statements and valuation logic.For the secondary market, an increase in the proportion of "recurring revenue" often implies that a company will shift from the valuation logic of a pure hardware manufacturer to the more premium logic of a medical technology service platform.

Miele also stated, "Accuray has a strong foundation of innovation, a large user base, a group of loyal dealer partners, and tremendous potential to further enhance its commercial impact globally." He also mentioned that he will "focus on promoting and selling value-added solutions to customers."

Combined with Accuray's previous actions, the appointment of the new CCO constitutes the "other half" of a complete tactical closed loop. By the end of 2025, under La Neve’s leadership, Accuray initiated a global workforce reduction plan affecting approximately 15% of its employees, aiming to strictly control costs and focus on high-profit businesses.After completing the "streamlining and cost reduction" of the internal organization, the hiring of Miele, who has extensive experience in activating and monetizing existing assets, aims to promote the "efficiency enhancement and quality improvement" of external revenue.

Taking a step back, Paul Miele's shift from Johnson & Johnson's robotic track to Accuray's precision radiotherapy track is not an isolated case. In recent years, a group of top executives who once led the da Vinci surgical robot and Johnson & Johnson's surgical equipment commercial sector have gradually flowed to giants in radiotherapy and imaging equipment.

This trend also indirectly reflects that business leaders who are adept at precisely driving order closures in long sales cycles and can continuously generate cash flow through follow-up services and product upgrades, while possessing the ability to manage the entire lifecycle of complex equipment, are gradually evolving from "specialists" in specific sectors into versatile strategic assets capable of moving across different niche fields.